Protagonist Therapeutics Inc (PTGX)

Gross profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Gross profit (ttm)	US$ in thousands	432,721	321,251	315,749	311,653	56,688	-2,736	-2,762	-1,925	23,796	31,850	42,989	45,238	26,538	24,390	27,218	31,170	28,628	25,697	16,724	-456
Revenue (ttm)	US$ in thousands	434,433	323,795	319,120	314,953	60,000	0	0	859	26,581	35,198	45,484	46,890	27,357	24,390	27,218	31,170	28,628	25,697	16,724	2,318
Gross profit margin		99.61%	99.21%	98.94%	98.95%	94.48%	—	—	-224.10%	89.52%	90.49%	94.51%	96.48%	97.01%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	-19.67%

December 31, 2024 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $432,721K ÷ $434,433K
= 99.61%

The gross profit margin of Protagonist Therapeutics Inc has exhibited significant fluctuations over the years. From March 31, 2020, where it was at a negative 19.67%, the company experienced a substantial improvement in the following quarters with margins reaching 100.00% by June 30, 2020, and maintaining this level until March 31, 2021.

However, starting from December 31, 2021, the gross profit margin began to decline slightly, reaching 97.01%. The margin continued to decrease in the subsequent quarters, dropping to 89.52% by December 31, 2022. There was a sharp decline in the margin to -224.10% on March 31, 2023, indicating that the cost of goods sold exceeded the revenue generated from sales during that period.

The company did not provide data for the gross profit margin for June 30, 2023, and September 30, 2023. Nevertheless, the margin recovered to 94.48% by December 31, 2023, and showed an upward trend in the following quarters, hitting 99.61% by December 31, 2024.

Overall, fluctuations in Protagonist Therapeutics Inc's gross profit margin demonstrate variations in the company's ability to effectively manage production costs and generate revenue from its core business activities. These changes could be influenced by various factors such as pricing strategies, changes in production efficiency, or shifts in the market demand for its products.